Template:Endothelial antihypertensives/ja: Difference between revisions

Line 1:

{{Navbox

| name = Sympatholytic antihypertensives/ja

| title = [[Sympatholytic/ja|~~交感神経溶解薬~~]]（および密接に関連した）[[antihypertensive/ja|抗高血圧薬]] ([[ATC code C02/ja|C02]])

| title = [[Sympatholytic/ja|交感神経遮断薬]]（および密接に関連した）[[antihypertensive/ja|抗高血圧薬]] ([[ATC code C02/ja|C02]])

| state = {{{state<includeonly>|autocollapse</includeonly>}}}

| listclass = hlist

| group1 = [[Sympatholytic]]s (~~antagonize~~ [[Adrenergic receptor#.CE.B1 receptors|α-~~adrenergic~~]] [[vasoconstriction]])

| group1 = [[Sympatholytic/ja|交感神経遮断薬]] (拮抗薬 [[Adrenergic receptor/ja#.CE.B1 receptors|α-アドレナリン]] [[vasoconstriction/ja|血管収縮]])

| list1 = {{Navbox|child

Line 11:

| list1 = {{Navbox|child

| group1 = [[Alpha-adrenergic agonist#.CE.B12 agonists|α2-~~Adrenergic receptor agonist~~]]s

| group1 = [[Alpha-adrenergic agonist/ja#.CE.B12 agonists|α2-アドレナリン受容体作動薬]]s

| list1 =

* [[Clonidine]]

* [[Clonidine/ja]]

* [[Guanabenz]]

* [[Guanabenz/ja]]

* [[Guanfacine]]

* [[Guanfacine/ja]]

* [[Guanoxabenz]]

* [[Guanoxabenz/ja]]

* [[Methyldopa]]#

* [[Methyldopa/ja]]#

* [[Tiamenidine]]‡

* [[Tiamenidine/ja]]‡

| group2 = [[Adrenergic release inhibitor]]s

| group2 = [[Adrenergic release inhibitor/ja|アドレナリン放出抑制剤]]

| list2 =

* [[Bethanidine]]

* [[Bethanidine/ja]]

* [[Bretylium]]

* [[Bretylium/ja]]

* [[Debrisoquine]]

* [[Debrisoquine/ja]]

* [[Guanadrel]]

* [[Guanadrel/ja]]

* [[Guanazodine]]

* [[Guanazodine/ja]]

* [[Guancydine]]

* [[Guancydine/ja]]

* [[Guanethidine]]

* [[Guanethidine/ja]]

* [[Guanoclor]]

* [[Guanoclor/ja]]

* [[Guanoxan]]

* [[Guanoxan/ja]]

| group3 = [[Imidazoline receptor]] ~~agonists~~

| group3 = [[Imidazoline receptor/ja|イミダゾリン受容体]]作動薬

| list3 =

* [[Moxonidine]]

* [[Moxonidine/ja]]

* [[Rilmenidine]]

* [[Rilmenidine/ja]]

* [[Tolonidine]]

* [[Tolonidine/ja]]

| group4 = [[Ganglionic blocker|~~Ganglion-blocking~~]]/[[nicotinic antagonist]]s

| group4 = [[Ganglionic blocker/ja|神経節遮断]]/[[nicotinic antagonist/ja|ニコチン拮抗薬]]

| list4 =

* [[Hexamethonium]]‡

* [[Hexamethonium/ja]]‡

* [[Mecamylamine]]

* [[Mecamylamine/ja]]

* [[Pentolinium]]

* [[Pentolinium/ja]]

* [[Trimetaphan camsilate|~~Trimethaphan~~]]

* [[Trimetaphan camsilate/ja|トリメタファン]]

}}

| group2 = ~~Peripheral~~

| group2 = 周辺

| list2 = {{Navbox|child

| group1 = ~~Indirect~~

| group1 = 間接的

| list1 = {{Navbox|child

| group1 = [[Monoamine oxidase inhibitor]]s

| group1 = [[Monoamine oxidase inhibitor/ja]]

| list1 =

* [[Pargyline]]‡

* [[Pargyline/ja]]‡

| group2 = [[VMAT inhibitor]]s

| group2 = [[VMAT inhibitor/ja]]

| list2 =

* [[Bietaserpine]]

* [[Bietaserpine/ja]]

* [[Deserpidine]]

* [[Deserpidine/ja]]

* [[Methoserpidine]]

* [[Methoserpidine/ja]]

* [[Reserpine]]

* [[Reserpine/ja]]

* [[Syrosingopine]]

* [[Syrosingopine/ja]]

| group3 = [[Tyrosine hydroxylase inhibitor]]s

| group3 = [[Tyrosine hydroxylase inhibitor/ja]]

| list3 =

* [[Metirosine]]

* [[Metirosine/ja]]

}}

| group2 = ~~Direct~~

| group2 = 直接的

| list2 = {{Navbox|child

| group1 = [[Alpha-1 blocker|α1-~~Adrenergic receptor blocker~~]]s

| group1 = [[Alpha-1 blocker/ja|α1-アドレナリン受容体遮断薬]]

| list1 =

* [[Doxazosin]]

* [[Doxazosin/ja]]

* [[Ketanserin]]

* [[Ketanserin/ja]]

* [[Indoramin]]

* [[Indoramin/ja]]

* [[Prazosin]]

* [[Prazosin/ja]]

* [[Trimazosin]]

* [[Trimazosin/ja]]

* [[Urapidil]]

* [[Urapidil/ja]]

| group2 = [[Alpha blocker|~~Non~~-~~selective α-adrenergic receptor blockers~~]]

| group2 = [[Alpha blocker/ja|非選択性α-アドレナリン受容体遮断薬]]

| list2 =

* [[Phentolamine]]

* [[Phentolamine/ja]]

}}

Line 91:

}}

| group2 = ~~Other~~ [[Receptor antagonist|~~antagonist~~]]s

| group2 = その他 [[Receptor antagonist/ja|拮抗薬]]

| list2 = {{Navbox|child

| group1 = [[Serotonin receptor antagonist]]s

| group1 = [[Serotonin receptor antagonist/ja]]

| list1 =

* [[Ketanserin]]

* [[Ketanserin/ja]]

* [[Lidanserin]]

* [[Lidanserin/ja]]

| group2 = [[Endothelin receptor antagonist]]s (~~for~~ {{Abbrlink|PH|Pulmonary hypertension}})

| group2 = [[Endothelin receptor antagonist/ja]] ({{Abbrlink|PH|Pulmonary hypertension/ja}}用)

| list2 =

* ''~~dual~~'' ([[Bosentan]], [[Macitentan]])

* ''デュアル'' ([[Bosentan/ja]], [[Macitentan/ja]])

* ''~~selective~~'' ([[Ambrisentan]], [[Sitaxentan]])

* ''選択的'' ([[Ambrisentan/ja]], [[Sitaxentan/ja]])

}}

| belowstyle = background: transparent; padding: 0px;

| below = {{PharmNavFootnote}}

| below = {{PharmNavFootnote/ja}}

}}<noinclude>

@@ Line 1: / Line 1: @@
 {{Navbox
   | name = Sympatholytic antihypertensives/ja
-  | title = [[Sympatholytic/ja|交感神経溶解薬]]（および密接に関連した）[[antihypertensive/ja|抗高血圧薬]] ([[ATC code C02/ja|C02]])
+  | title = [[Sympatholytic/ja|交感神経遮断薬]]（および密接に関連した）[[antihypertensive/ja|抗高血圧薬]] ([[ATC code C02/ja|C02]])
   | state = {{{state<includeonly>|autocollapse</includeonly>}}}
   | listclass = hlist
-  | group1 = [[Sympatholytic]]s<br />(antagonize [[Adrenergic receptor#.CE.B1 receptors|α-adrenergic]]<br />[[vasoconstriction]])
+  | group1 = [[Sympatholytic/ja|交感神経遮断薬]]<br />(拮抗薬 [[Adrenergic receptor/ja#.CE.B1 receptors|α-アドレナリン]]<br />[[vasoconstriction/ja|血管収縮]])
   | list1 = {{Navbox|child
@@ Line 11: / Line 11: @@
     | list1 = {{Navbox|child
-      | group1 = [[Alpha-adrenergic agonist#.CE.B12 agonists|α<sub>2</sub>-Adrenergic receptor agonist]]s
+      | group1 = [[Alpha-adrenergic agonist/ja#.CE.B12 agonists|α<sub>2</sub>-アドレナリン受容体作動薬]]s
       | list1 =
-* [[Clonidine]]
+* [[Clonidine/ja]]
-* [[Guanabenz]]
+* [[Guanabenz/ja]]
-* [[Guanfacine]]
+* [[Guanfacine/ja]]
-* [[Guanoxabenz]]
+* [[Guanoxabenz/ja]]
-* [[Methyldopa]]<sup>#</sup>
+* [[Methyldopa/ja]]<sup>#</sup>
-* [[Tiamenidine]]<sup>‡</sup>
+* [[Tiamenidine/ja]]<sup>‡</sup>
-      | group2 = [[Adrenergic release inhibitor]]s
+      | group2 = [[Adrenergic release inhibitor/ja|アドレナリン放出抑制剤]]
       | list2 =
-* [[Bethanidine]]
+* [[Bethanidine/ja]]
-* [[Bretylium]]
+* [[Bretylium/ja]]
-* [[Debrisoquine]]
+* [[Debrisoquine/ja]]
-* [[Guanadrel]]
+* [[Guanadrel/ja]]
-* [[Guanazodine]]
+* [[Guanazodine/ja]]
-* [[Guancydine]]
+* [[Guancydine/ja]]
-* [[Guanethidine]]
+* [[Guanethidine/ja]]
-* [[Guanoclor]]
+* [[Guanoclor/ja]]
-* [[Guanoxan]]
+* [[Guanoxan/ja]]
-      | group3 = [[Imidazoline receptor]] agonists
+      | group3 = [[Imidazoline receptor/ja|イミダゾリン受容体]]作動薬
       | list3 =
-* [[Moxonidine]]
+* [[Moxonidine/ja]]
-* [[Rilmenidine]]
+* [[Rilmenidine/ja]]
-* [[Tolonidine]]
+* [[Tolonidine/ja]]
-      | group4 = [[Ganglionic blocker|Ganglion-blocking]]/[[nicotinic antagonist]]s
+      | group4 = [[Ganglionic blocker/ja|神経節遮断]]/[[nicotinic antagonist/ja|ニコチン拮抗薬]]
       | list4 =
-* [[Hexamethonium]]<sup>‡</sup>
+* [[Hexamethonium/ja]]<sup>‡</sup>
-* [[Mecamylamine]]
+* [[Mecamylamine/ja]]
-* [[Pentolinium]]
+* [[Pentolinium/ja]]
-* [[Trimetaphan camsilate|Trimethaphan]]
+* [[Trimetaphan camsilate/ja|トリメタファン]]
     }}
-    | group2 = Peripheral
+    | group2 = 周辺
     | list2 = {{Navbox|child
-      | group1 = Indirect
+      | group1 = 間接的
       | list1 = {{Navbox|child
-        | group1 = [[Monoamine oxidase inhibitor]]s
+        | group1 = [[Monoamine oxidase inhibitor/ja]]
         | list1 =
-* [[Pargyline]]<sup>‡</sup>
+* [[Pargyline/ja]]<sup>‡</sup>
-        | group2 = [[VMAT inhibitor]]s
+        | group2 = [[VMAT inhibitor/ja]]
         | list2 =
-* [[Bietaserpine]]
+* [[Bietaserpine/ja]]
-* [[Deserpidine]]
+* [[Deserpidine/ja]]
-* [[Methoserpidine]]
+* [[Methoserpidine/ja]]
-* [[Reserpine]]
+* [[Reserpine/ja]]
-* [[Syrosingopine]]
+* [[Syrosingopine/ja]]
-        | group3 = [[Tyrosine hydroxylase inhibitor]]s
+        | group3 = [[Tyrosine hydroxylase inhibitor/ja]]
         | list3 =
-* [[Metirosine]]
+* [[Metirosine/ja]]
       }}
-      | group2 = Direct
+      | group2 = 直接的
       | list2 = {{Navbox|child
-        | group1 = [[Alpha-1 blocker|α<sub>1</sub>-Adrenergic receptor blocker]]s
+        | group1 = [[Alpha-1 blocker/ja|α<sub>1</sub>-アドレナリン受容体遮断薬]]
         | list1 =
-* [[Doxazosin]]
+* [[Doxazosin/ja]]
-* [[Ketanserin]]
+* [[Ketanserin/ja]]
-* [[Indoramin]]
+* [[Indoramin/ja]]
-* [[Prazosin]]
+* [[Prazosin/ja]]
-* [[Trimazosin]]
+* [[Trimazosin/ja]]
-* [[Urapidil]]
+* [[Urapidil/ja]]
-        | group2 = [[Alpha blocker|Non-selective α-adrenergic receptor blockers]]
+        | group2 = [[Alpha blocker/ja|非選択性α-アドレナリン受容体遮断薬]]
         | list2 =
-* [[Phentolamine]]
+* [[Phentolamine/ja]]
       }}
@@ Line 91: / Line 91: @@
   }}
-  | group2 = Other [[Receptor antagonist|antagonist]]s
+  | group2 = その他 [[Receptor antagonist/ja|拮抗薬]]
   | list2 = {{Navbox|child
-    | group1 = [[Serotonin receptor antagonist]]s
+    | group1 = [[Serotonin receptor antagonist/ja]]
     | list1 =
-* [[Ketanserin]]
+* [[Ketanserin/ja]]
-* [[Lidanserin]]
+* [[Lidanserin/ja]]
-    | group2 = [[Endothelin receptor antagonist]]s (for {{Abbrlink|PH|Pulmonary hypertension}})
+    | group2 = [[Endothelin receptor antagonist/ja]] ({{Abbrlink|PH|Pulmonary hypertension/ja}}用)
     | list2 =
-* ''dual'' ([[Bosentan]], [[Macitentan]])
+* ''デュアル'' ([[Bosentan/ja]], [[Macitentan/ja]])
-* ''selective'' ([[Ambrisentan]], [[Sitaxentan]])
+* ''選択的'' ([[Ambrisentan/ja]], [[Sitaxentan/ja]])
   }}
   | belowstyle = background: transparent; padding: 0px;
-  | below = {{PharmNavFootnote}}
+  | below = {{PharmNavFootnote/ja}}
 }}<noinclude>